Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma

What Was Tested

The paper reports a study of ANP (Atrial Natriuretic Peptide) in the context of low blood pressure and orthostatic hypotension, published as a randomized controlled trial.

The effect of salt restriction on blood pressure is under intense debate.

Furthermore, the researchers tested whether the basal plasma concentration of renin or N-terminal atrial natriuretic peptide (Nt-proANP) predict the degree of salt sensitivity.

Who Took Part

According to the abstract, 46 individuals were involved.

PubMed indexes the participants as middle-aged adults, both men and women.

How the Study Was Run

The design is described as randomized, double-blind, placebo-controlled and crossover.

Because people in this ANP (Atrial Natriuretic Peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Neither the individuals nor the staff measuring them knew who was on ANP (Atrial Natriuretic Peptide), so expectations could not easily colour the readings.

The comparison arm used a placebo, so changes seen with ANP (Atrial Natriuretic Peptide) could be set against what happens without it.

In the crossover set-up each of the individuals took both ANP (Atrial Natriuretic Peptide) and the comparison in turn, acting as their own control.

Salt sensitivity was defined as the difference between 24-h systolic ABP at the high-salt versus the low-salt periods.

Baseline renin and Nt-proANP were related to salt sensitivity.

What Was Measured

Topics PubMed links to this paper include Atrial Natriuretic Factor, Biomarkers, Blood Pressure, Blood Pressure Monitoring, Ambulatory, Diet, Sodium-Restricted, Hypertension and Renin.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of ANP (Atrial Natriuretic Peptide) in 46 individuals in people with low blood pressure and orthostatic hypotension.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2007 (Journal of hypertension), a journal based in Netherlands.

More context: the ANP (Atrial Natriuretic Peptide) compound page, Low blood pressure and orthostatic hypotension research.